phase readout
saveNCT06864169: A Study of Raludotatug Deruxtecan (R-DXd) in People With Gastrointestinal Cancers (MK-5909-005)
ACTIVE_NOT_RECRUITINGupdated 1mo ago
community read0 votes
Sponsor: Merck Sharp & Dohme LLC. Phase: PHASE2. Conditions: Gastrointestinal Cancer
view source ↗
comments(0)
5-min edit window · permanent after that